| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1035871535 |
| P356 | DOI | 10.1054/BJOC.2000.1660 |
| P8608 | Fatcat ID | release_2tzqqma7trhohd6243y6vfl2fy |
| P932 | PMC publication ID | 2363812 |
| P698 | PubMed publication ID | 11259087 |
| P5875 | ResearchGate publication ID | 12073731 |
| P2093 | author name string | G Thomas | |
| H Wang | |||
| R D Odze | |||
| C Eng | |||
| M H Kulke | |||
| M Loda | |||
| K S Thakore | |||
| P2860 | cites work | P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase | Q24322705 |
| Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers | Q28145813 | ||
| PTEN1 is frequently mutated in primary endometrial carcinomas | Q28250937 | ||
| MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines | Q28256046 | ||
| Role of the p16 tumor suppressor gene in cancer | Q28265169 | ||
| Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers | Q28306997 | ||
| Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome | Q29615538 | ||
| PTEN/MMAC1 is infrequently mutated in pT2 and pT3 carcinomas of the prostate. | Q30472730 | ||
| Germline PTEN mutations in Cowden syndrome-like families. | Q33681468 | ||
| Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer | Q34436736 | ||
| PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome | Q34504165 | ||
| Epigenetic PTEN silencing in malignant melanomas without PTEN mutation | Q35745799 | ||
| Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors | Q35810225 | ||
| Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression | Q36067596 | ||
| Allelotype analysis of oesophageal adenocarcinoma: loss of heterozygosity occurs at multiple sites | Q36115450 | ||
| Somatic mutation of PTEN in bladder carcinoma | Q36617723 | ||
| Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma. | Q36618853 | ||
| Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas | Q36618879 | ||
| Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas. | Q36619048 | ||
| Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers | Q36951846 | ||
| Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. | Q38467346 | ||
| Low p27 expression predicts poor disease-free survival in patients with prostate cancer | Q38472792 | ||
| Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma | Q38530938 | ||
| Mutation analysis of the p53, APC, and p16 genes in the Barrett's oesophagus, dysplasia, and adenocarcinoma | Q39563836 | ||
| Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN | Q39711051 | ||
| Somatic mutation and homozygous deletion of PTEN/MMAC1 gene of 10q23 in renal cell carcinoma | Q40907210 | ||
| PTEN gene alterations in lymphoid neoplasms | Q41000268 | ||
| Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. | Q42815905 | ||
| Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines | Q42818580 | ||
| Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma | Q43725713 | ||
| PTEN gene mutations are seen in high-grade but not in low-grade gliomas. | Q44846579 | ||
| Mutational analysis of the PTEN/MMAC1 gene in non-Hodgkin's lymphoma | Q47712787 | ||
| PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers | Q47720095 | ||
| Mutational analysis of the PTEN gene in head and neck squamous cell carcinoma | Q47751177 | ||
| PTEN/MMAC1/TEP1 involvement in primary prostate cancers. | Q47814101 | ||
| Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers | Q47814180 | ||
| Allelic loss of chromosome 10q23 is associated with tumor progression in breast carcinomas | Q47814647 | ||
| PTEN mutations in gliomas and glioneuronal tumors. | Q47995275 | ||
| Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. | Q48030071 | ||
| Germline mutations in PTEN are present in Bannayan-Zonana syndrome | Q48046915 | ||
| Mutational analysis of the PTEN gene in gliomas: molecular and pathological correlations | Q48252490 | ||
| Inactivation of the PTEN/MMAC1/TEP1 gene in human lung cancers | Q48464018 | ||
| Analysis of PTEN/MMAC1 alterations in aerodigestive tract tumors. | Q48544624 | ||
| Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q. | Q48566471 | ||
| Somatic mutations of PTEN in glioblastoma multiforme | Q48618632 | ||
| Abnormal structure and expression of PTEN/MMAC1 gene in human uterine cancers. | Q52537916 | ||
| Biallelic inactivating mutations and an occult germline mutation of PTEN in primary cervical carcinomas. | Q52540667 | ||
| PTEN/MMAC1 mutations in endometrial cancers. | Q53439663 | ||
| Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. | Q53439669 | ||
| Mutations of p53 in Barrett's esophagus and Barrett's cancer: a prospective study of ninety-eight cases. | Q53457025 | ||
| Analysis of PTEN mutations and deletions in B-cell non-Hodgkin's lymphomas. | Q55477059 | ||
| PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas. | Q55477977 | ||
| PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. | Q55478126 | ||
| PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies | Q57591287 | ||
| Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma | Q58204833 | ||
| TP53 gene mutations and p53 protein immunoreactivity in malignant and premalignant Barrett's esophagus | Q58409008 | ||
| Expression of p53 protein in oesophageal carcinoma: clinicopathological correlation and prognostic significance | Q60632753 | ||
| Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers | Q67920829 | ||
| Rising incidence of adenocarcinoma of the esophagus and gastric cardia | Q68199481 | ||
| Allelotype analysis of esophageal adenocarcinomas: evidence for the involvement of sequences on the long arm of chromosome 4 | Q71545574 | ||
| Base transitions at CpG dinucleotides in the p53 gene are common in esophageal adenocarcinoma | Q71887355 | ||
| p53 protein expression in Barrett's adenocarcinoma: a frequent event with no prognostic significance | Q72195645 | ||
| p53 mutations in Barrett's adenocarcinoma and high-grade dysplasia | Q72463048 | ||
| The MTS1 gene is frequently mutated in primary human esophageal tumors | Q72831620 | ||
| The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas | Q73221172 | ||
| Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype | Q73316223 | ||
| Allelic imbalance and mutations of the PTEN gene in ovarian cancer | Q73340878 | ||
| Loss of heterozygosity on chromosome 9 andp16 (MTS1, CDKN2) gene mutations in esophageal cancers | Q73486608 | ||
| Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies | Q73722520 | ||
| Exclusion of PTEN and 10q22-24 as the susceptibility locus for juvenile polyposis syndrome | Q73883821 | ||
| Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues | Q74093343 | ||
| Sporadic breast cancers exhibit loss of heterozygosity on chromosome segment 10q23 close to the Cowden disease locus | Q74274255 | ||
| Analysis of PTEN and the 10q23 region in primary prostate carcinomas | Q74531155 | ||
| Alterations of the MMAC1/PTEN gene in lymphoid malignancies | Q74576991 | ||
| PTEN mutations in endometrial cancers with 10q LOH: additional evidence for the involvement of multiple tumor suppressors | Q77789624 | ||
| Loss of heterozygosity at 10q in tumors of the upper respiratory tract is associated with poor prognosis | Q77995588 | ||
| Mutation analysis of the putative tumor suppression gene PTEN/MMAC1 in sporadic breast cancer | Q78206096 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 748-753 | |
| P577 | publication date | 2001-03-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Allelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma | |
| P478 | volume | 84 |
| Q33287238 | Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study |
| Q39698340 | Assessment of mutational load in biopsy tissue provides additional information about genomic instability to histological classifications of Barrett's esophagus. |
| Q49816565 | Computational methods reveal novel functionalities of PIWI-interacting RNAs in human papillomavirus-induced head and neck squamous cell carcinoma. |
| Q40203442 | Inhibition of c-Met as a therapeutic strategy for esophageal adenocarcinoma |
| Q33449893 | Loss of heterozygosity at thymidylate synthase locus in Barrett's metaplasia, dysplasia, and carcinoma sequences |
| Q57591227 | Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma |
| Q43456119 | Prognostic significance of PTEN expression in esophageal squamous cell carcinoma from Linzhou City, a high incidence area of northern China |
Search more.